Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
BMC Complementary Medicine and Therapies|September 6, 2024
Effect of Sitting Baduanjin exercise on early rehabilitation of sepsis patients with non-invasive ventilation : a randomized controlled trialMing-Gui Chen, Fangfang Wang, Lixia Huang, et al.
Atherosclerosis|December 3, 2014
Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetesRui-Xiang Zeng, Xiao-Lin Li, Min-Zhou Zhang, et al.
Chinese Journal of Integrative Medicine|October 28, 2016
Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivoJian-Yong Qi, Juan Yu, Dong-Hui Huang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 28, 2020
Effect of Baduanjin Sequential Therapy on the Quality of Life and Cardiac Function in Patients with AMI After PCI: A Randomized Controlled TrialMing-Gui Chen, Xuefei Liang, Lili Kong, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|January 28, 2023
Systemic inflammation markers and the prevalence of hypertension: A NHANES cross-sectional studyJun-Peng Xu, Rui-Xiang Zeng, Yu-Zhuo Zhang, et al.
Frontiers in Endocrinology|October 29, 2024
The associations of the triglyceride-glucose index and its combination with blood pressure on cardiovascular and all-cause mortality in hypertension: a national studyJun-Peng Xu, Xiong-Qiang Peng, Li-Heng Guo, et al.
Chinese Medical Journal|February 4, 2006
XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in ChinaKe-ji Chen, Da-zhuo Shi, Hao Xu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|June 28, 2014
A multicentre randomized clinical trial on efficacy and safety of huxin formula in patients undergoing percutaneous coronary interventionHuan-Lin Wu, Yun-Fei Wang, Jun-Zhe Li, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 24, 2015
Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunctionRui-Xiang Zeng, Xiao-Lin Li, Min-Zhou Zhang, et al.
Oncotarget|November 9, 2017
Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years oldXiong-Yi Gao, Bing-Yang Zhou, Min-Zhou Zhang, et al.
Pageof 6